Effects of hormone replacement therapy on ambulatory blood pressure and vascular responses in normotensive women

Blood Pressure

Volumn 9, Issue 1, 2000, Pages 22-27

  Manwaring, Paul ^a   Morfis, Litsa ^a   Diamond, Terence ^a   Howes, Laurence G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Ambulatory monitoring; Blood pressure; Forearm vascular resistance; Hormone replacement therapy; Oestrogen

Indexed keywords

ACETYLCHOLINE; ALDOSTERONE; ANGIOTENSIN; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; NEUROHORMONE; NITROPRUSSIDE SODIUM; NORADRENALIN; RENIN;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SUBSTITUTION; HUMAN; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; VASCULAR RESISTANCE;

EID: 0034045644     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370500439380     Document Type: Article

References (15)

1. Luotola H, Pyorala T, Lahteenmaki P, Toivanen J. Haemodynamic and hormonal effects of short-term oestradiol treatment in postmenopausal women. Maturitas 1979; 1: 287-94.
2. PEPI Trial. Effects of estrogen of estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995; 273: 199-208.
3. Mercuro O, Zoncu S, Pilia I, Lao A, Melis GB, Cherchi A. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Am J Cardiol 1997; 80: 652-5.
4. Mercuro G, Zoncu S, Piano D, et al. Estradiol-17 beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens 1998; 11: 909-13.
5. Akkad AA, Halligan AW, Abrams K, Al-Azzawi F. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol 1997; 89: 97-103.
6. Van Ittersum FJ, Van Baal WM, Kennemans P. et al. Ambulatory - not office - blood pressures decline during hormone replacement therapy in healthy postmenopausal women. Am J Hypertens 1998; 11: 1147-52.
7. Harvey PJ, Wing LM, Savage J, Molloy D. The effects of different types and doses of oestrogen replacement on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women. Am J Hypertens 1998; 11: 1147-52.
8. Sudhir K, Elser MD, Jennings GL, Komesaroff PA. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 1997; 30: 1538-43.
9. Sullivan JM, Shala BA, Miller LA, Lerner JL, McBrayer JD. Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy. Menopause 1995; 2: 193-9.
10. Kitazawa T, Hamada E, Kitazawa K, Gaznabi AK. Nongenomic mechanism of 17 beta-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle. J Physiol 1997; 499: 497-511.
11. White MM, Zamudio S, Stevens T, et al. Estrogen, progestogen and vascular reactivity: potential cellular mechanisms. Endocrinol Rev 1995; 16: 739-51.
12. Tagawa H, Shimokawa H, Tagawa T, et al. Short-term estrogen augments both nitric oxide-mediated and no-nitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal women. J Cardio Pharm 1997; 30: 481-8.
13. Pinto S, Virdis A, Ghiadoni L, et al. Endogenous estrogen and acetylcholine-induced vasodilution in normotensive women. Hypertension 1997; 2: 268-73.
14. Sudhir K, Jennings GL, Funder JW, Komesaroff PA. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension 1996; 28: 330-5.
15. Collins P, Beale CM, Rosano GMC. Oestrogen as a calcium channel blocker. Eur Heart J 1996; 17(Suppl D): 27-31.